Sermorelin: Research Peptide Guide

For research purposes only. This guide describes the chemical identity and laboratory handling of Sermorelin and summarises findings reported in published research. It is not medical advice and does not describe any effect, dose, or use in humans or animals.

What is Sermorelin?

Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth hormone-releasing hormone (GHRH 1-29), the N-terminal fragment of GHRH. It is supplied as a lyophilised powder for laboratory research.

PurePeptides offers Sermorelin at >99% purity strictly for in-vitro research use. This page describes its chemical identity and handling only.

Sermorelin corresponds exactly to the first 29 residues of growth hormone-releasing hormone (GHRH 1-29) — the N-terminal fragment recognised in endocrine research as the shortest sequence retaining full activity at the GHRH receptor. Unlike Modified GRF (1-29), sermorelin carries no stabilising substitutions, so in GHRH-analogue studies it serves as the “native fragment” reference point against which modified analogues are compared.

Chemical identity & specifications

Handling Sermorelin in research protocols

In laboratory settings, lyophilised Sermorelin is typically stored at -20°C, protected from light and moisture, until use. For reconstitution, bacteriostatic water is a commonly cited solvent; once in solution, the material is generally kept refrigerated at 2-8°C with freeze-thaw cycles minimised to preserve peptide integrity.

Researchers quantify Sermorelin by concentration within their experimental system — for example molar concentrations for in-vitro work, or amount-per-mass figures in animal models. These are parameters defined by the study design and reported in the literature; they are not dosing guidance for any human or animal use. To convert between vial mass, solvent volume, and target concentration for laboratory preparation, our peptide reconstitution calculator may be useful.

Findings reported in the research literature

Sermorelin / GRF (1-29) is one of the most established sequences in GHRH research — the minimal active N-terminal fragment of the native 44-residue hormone. It appears throughout GHRH-receptor literature as a reference compound in in-vitro and preclinical studies.

Any effects described in this literature are observations made in controlled experimental systems — cell assays and animal models — and are reported here only to summarise the scientific record. They do not constitute claims about outcomes, efficacy, benefits, or safety in humans, and nothing on this page should be read as encouraging human or animal use. Readers interested in the primary research can review the indexed literature via PubMed’s Sermorelin results.

The GHRH-analogue family: how Sermorelin compares

Sermorelin is studied alongside other peptides in growth-hormone-axis research. The GHRH analogues share a receptor target but differ in sequence and length; ipamorelin is included below for contrast as a ghrelin / GHS-receptor ligand:

Sermorelin, CJC-1295 (without DAC) and tesamorelin all act at the GHRH receptor, which distinguishes them from ghrelin / GHS-receptor ligands such as ipamorelin (see our separate ipamorelin guide). All of these peptides are supplied by PurePeptides strictly as research materials, with no claim regarding outcomes in humans or animals.

Purity and quality control in research-grade Sermorelin

In laboratory research, peptide purity has a direct bearing on reproducibility: synthesis by-products or residual reagents can confound experimental observations. PurePeptides supplies Sermorelin at greater than 99% purity as a lyophilised powder.

In peptide manufacturing, purity is typically assessed by reverse-phase high-performance liquid chromatography (HPLC), while identity is confirmed by mass spectrometry (MS) against the expected molecular weight — approximately 3358 g/mol for Sermorelin. A certificate of analysis (COA) documenting these results is available on request for the current batch. When evaluating any research-grade peptide, requesting the COA and confirming both the purity figure and the mass-spec identity is good laboratory practice.

Frequently asked questions

Research-grade Sermorelin

Greater than 99% purity, lyophilised powder, same-day dispatch before 3PM with tracked UK & EU delivery. Research use only.

Disclaimer: All products supplied by PurePeptides are strictly for laboratory research use only. They are not for human or animal consumption and are not medical products. This guide is informational and summarises publicly available research; it is not medical, clinical, or dosing advice.